Skip to main content

Pregabalin

NDC 71610-871 · Aphena Pharma Solutions - Tennessee, LLC

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength100 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

71610-871-30 — 30 CAPSULE in 1 BOTTLE (71610-871-30)

71610-871-46 — 56 CAPSULE in 1 BOTTLE (71610-871-46)

71610-871-53 — 60 CAPSULE in 1 BOTTLE (71610-871-53)

71610-871-92 — 270 CAPSULE in 1 BOTTLE (71610-871-92)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-758 — Pregabalin, 71610-759 — Pregabalin, 71610-760 — Pregabalin, 71610-765 — PREGABALIN, 71610-792 — Pregabalin, 71610-799 — Pregabalin, 71610-800 — PREGABALIN, 71610-808 — Pregabalin, 71610-820 — Pregabalin, 71610-845 — Pregabalin, 71610-882 — Pregabalin, 71610-887 — Pregabalin, 71610-894 — Pregabalin, 71610-925 — Pregabalin, 71610-926 — Pregabalin, 71610-930 — Pregabalin, 71610-931 — Pregabalin, 71610-936 — PREGABALIN, 71610-946 — Pregabalin, 71610-947 — Pregabalin, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels